OSN New York Retina Meeting


Evaluations and CME Certificates

Online evaluations will be available through November 17, 2021 (please email evals@HealioLive.com if you need your login credentials). Please email evals@HealioLive.com if you need assistance with this year’s credits or cme@VindicoMedEd.com if you need a certificate from a previous year.

Target Audience: General Sessions

The intended audience for this activity is retina specialists and other health care professionals involved in the management of patients with retinal disease.

Learning Objectives: General Sessions

Upon successful completion of this activity, participants should be better able to:

  • Assess advances in vitreoretinal surgery, including improvements in visualization, management of secondary intraocular lenses, implantation of drug reservoir systems, techniques for gene therapy surgery, and the use of anti-VEGF therapy in the perioperative period.
  • Evaluate therapies for diabetic macular edema (DME) and diabetic retinopathy (DR) including the treatment of non-proliferative and proliferative DR with anti-VEGF agents, the role of steroids in DME and DR, applying artificial intelligence to DR screening, and anti-VEGF treatment patterns for DME that lead to the most optimal visual outcome.
  • Explore the various issues that retina specialists face in managing both exudative and non-exudative age-related macular degeneration (AMD), including the role of the fluid in exudative AMD, treating every 12 weeks and beyond with anti-VEGF agents, managing refractory disease, exploring pathways beyond VEGF-A, and treatments for non-exudative AMD.
  • Describe the various imaging modalities and their place in the evaluation of the retina patient including ultra-widefield imaging, optical coherence tomography (OCT) angiography, swept source OCT, and imaging biomarkers that help differentiate various retinal conditions.
  • Summarize the latest evidence on various treatments for uveitis (including local and systemic immunosuppressive options), inherited retinal disorders, and for pediatric retinal conditions.

This continuing medical education activity is provided by

ACCREDITATION: Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT DESIGNATION: Vindico Medical Education designates this live activity for a maximum of 13 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

FACULTY/PLANNER DISCLOSURE POLICY: In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all planners, teachers, and authors involved in the development of CME content are required to mitigate and disclose to the accredited provider their relevant financial relationships. Relevant financial relationships will be disclosed to the activity audience.

NOTICE: Faculty, topics, program schedule and credit hours are subject to change. Audiotaping or videotaping is prohibited without written permission from the program director and the Office of Medical Affairs and Compliance.